SARS‐CoV‐2, bacterial co‐infections, and AMR: the deadly trio in COVID‐19?

Graphical Abstract Respiratory viral infections are well known to predispose patients to bacterial co‐infections and superinfections. Still, there is limited reference to these in COVID‐19. Do co‐infections play a significant role during COVID‐19? What is the impact of antimicrobial resistance?...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	EMBO molecular medicine 2020-07, Vol.12 (7), p.e12560-n/a
Hauptverfasser:	Bengoechea, Jose A, Bamford, Connor GG
Format:	Artikel
Sprache:	eng
Schlagworte:	Bacteria Bacterial infections Betacoronavirus Chronic obstructive pulmonary disease Cohort Studies Coinfection Coronavirus Infections Coronaviruses COVID-19 Cytokines EMBO23 Enterocytes Epidemics Humans Immune response Infections Influenza Intensive care Intestinal microflora Lung diseases Mechanical ventilation Microbiota Mortality Obstructive lung disease Opinion Pandemics Pathogens Pneumonia Pneumonia, Viral Prospective Studies SARS Virus SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Swine flu United Kingdom Viral infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Graphical Abstract Respiratory viral infections are well known to predispose patients to bacterial co‐infections and superinfections. Still, there is limited reference to these in COVID‐19. Do co‐infections play a significant role during COVID‐19? What is the impact of antimicrobial resistance?
ISSN:	1757-4676 1757-4684
DOI:	10.15252/emmm.202012560